Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.

Breast Cancer Research and Treatment
Yuan YaoQun Zhou

Abstract

Exposure to higher levels of estrogen produces genotoxic metabolites that can stimulate mammary tumorigenesis. Induction of NF-E2-related factor 2 (NRF2)-dependent detoxifying enzymes (e.g., NAD(P)H-quinone oxidoreductase 1 (NQO1)) is considered an important mechanism of protection against estrogen-associated carcinogenesis because they would facilitate removal of toxic estrogens. Here, we studied the impact of estrogen-receptor (ER) signaling on NRF2-dependent gene transcription. In luciferase assay experiments using the 5-flanking region of the human NQO1 gene promoter, we observe that ERα ligand-binding domain (LBD) is required for estrogen inhibition of NQO1 promoter activity in estrogen-dependent breast cancer cells. Chromatin immunoprecipitation (ChIP) assay shows that estrogen recruits ERα and a class III histone deacetylase SIRT1 at the NQO1 promoter, leading to inhibition of NQO1 transcription. Inhibition of ERα expression by the antiestrogen shikonin reverses the inhibitory effect of estrogen on NQO1 expression. As a consequence, a chemoprevention study was undertaken to monitor the impact of shikonin on DNA lesions and tumor growth. Treatment of MCF-7 breast cancer cells with shikonin inhibits estrogen-induced 8-hydr...Continue Reading

References

Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·E L CavalieriE G Rogan
Jul 27, 1999·The Journal of Steroid Biochemistry and Molecular Biology·G S TakimotoK B Horwitz
Mar 4, 2000·Endocrine Reviews·J G Liehr
Aug 8, 2002·Phytotherapy Research : PTR·Xin ChenM Zack Howard
Sep 17, 2002·Proceedings of the National Academy of Sciences of the United States of America·Gad AsherYosef Shaul
Nov 19, 2003·The Journal of Steroid Biochemistry and Molecular Biology·W YueE L Cavalieri
Mar 18, 2004·Journal of the National Cancer Institute·Brian J LongAngela M Brodie
Apr 6, 2005·Proceedings of the National Academy of Sciences of the United States of America·Peter TsvetkovJoseph Lotem
Jun 21, 2005·The Journal of Biological Chemistry·Judith C KeenNancy E Davidson
Jan 20, 2006·The New England Journal of Medicine·James D Yager, Nancy E Davidson
Sep 14, 2006·Annual Review of Pharmacology and Toxicology·Thomas W KenslerShyam Biswal
Oct 6, 2006·PLoS Medicine·Anju SinghShyam Biswal
Jan 24, 2009·International Journal of Cancer. Journal International Du Cancer·Huanjie YangJinbao Liu
Sep 8, 2009·Toxicology and Applied Pharmacology·Mi-Kyoung Kwak, Thomas W Kensler
Oct 2, 2009·Carcinogenesis·Thomas W Kensler, Nobunao Wakabayashi

❮ Previous
Next ❯

Citations

Jun 4, 2011·Breast Cancer Research and Treatment·Muhua YangQun Zhou
Sep 20, 2011·The Journal of Biological Chemistry·Gabriel EadesQun Zhou
Oct 26, 2012·Proceedings. Biological Sciences·Yibayiri O SanogoAlison M Bell
Sep 17, 2011·Cancer Research·Selvakumar ElangovanMuthusamy Thangaraju
Jul 23, 2011·Chinese Medicine·Wen TanYitao Wang
Oct 4, 2012·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Frederick L CraneRafael de Cabo
Mar 7, 2014·Journal of Cancer Research and Clinical Oncology·MingJun XiangXiaoLi Wang
Feb 21, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Changmin ChenAndrew L Kung
Jun 1, 2012·Drug Discovery Today. Disease Mechanisms·Courtney S SneltenJudy L Bolton
Jun 16, 2015·Environment International·Ryoiti Kiyama, Yuko Wada-Kiyama
Apr 24, 2012·Journal of Applied Toxicology : JAT·Jeffrey C SivilsLisa J Bain
Nov 15, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hui TianJunNian Zheng
May 24, 2014·Biochimica Et Biophysica Acta·Akhileshwar NamaniXiuwen Tang
Aug 1, 2015·Cell Death & Disease·M F SantollaM Maggiolini
Dec 20, 2012·Epigenetics : Official Journal of the DNA Methylation Society·Raffaela BarbanoPaola Parrella
Oct 2, 2014·Biochimica Et Biophysica Acta·Monique G P van der WijstMarianne G Rots
Mar 19, 2015·Breast Cancer Research and Treatment·Ramkishore GernapudiQun Zhou
Nov 6, 2013·Proceedings of the National Academy of Sciences of the United States of America·Hua Liu, Paul Talalay
Feb 1, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Xianchun WenYonghui Wu
Sep 1, 2011·American Journal of Physiology. Endocrinology and Metabolism·Anna VeprikYoav Sharoni
Feb 29, 2016·Journal of Hematology & Oncology·Yijun TianKongming Wu
Apr 24, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Sarmistha Mitra, Raju Dash
Nov 7, 2019·Antioxidants & Redox Signaling·Virginia Solar FernandezMarco Fiocchetti
Oct 16, 2018·Frontiers in Endocrinology·Sergio LiarteFrancisco José Nicolás
Apr 27, 2019·International Journal of Molecular Sciences·Pelin Telkoparan-AkillilarLuciano Saso
Jan 16, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jaana M HartikainenArto Mannermaa
Jan 7, 2021·Antioxidants & Redox Signaling·Emiliano Panieri, Luciano Saso
Jan 14, 2021·Antioxidants·Ewa Maria KratzAgnieszka Piwowar
Jul 31, 2021·The Journal of International Medical Research·Shu-Xin MaJia Li
Dec 27, 2017·The Journal of Investigative Dermatology·Michelle L KernsPierre A Coulombe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.